EUVIMEDObjevte EUVIMED
Open access · CC BY 3.0

Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines

Denzel R Woode, Harini S Aiyer, Nicole Sie, Alan L Zwart, Liya Li, Navindra P Seeram, Robert Clarke

International Journal of Breast Cancer · 2012

DOI: 10.1155/2012/147828 ↗

At a glance

Journal article in International Journal of Breast Cancer, 2012. Written by Denzel R Woode and 6 co-authors. Institution: Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA ; Columbia University, 5992 Lerner Hall, 2920 Broadway, New Yo…. Cited 7 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 3.0). Funded by: NCI NIH HHS, National Institutes of Health, American Institute for Cancer Research.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry extracts (Jamun-EJAE and red raspberry-RRE) and their bioactive compounds (Delphinidin-Del and Ellagic acid-EA) to inhibit cell proliferation with or without a sublethal dose of ICI in various breast cancer cell lines. ICI-sensitive (LCC1, ZR75-1, and BT474) and -resistant (LCC9, ZR75-1R) cells were subjected to treatment with berry extracts alone (0.1-100 μg/mL) or with a sub-lethal dose of ICI ( 1). EA, in doses tested, did not have any significant effects on any of the cell lines. Finally, we found that the extracts were more effective at lower, physiologically relevant concentrations than at higher experimental doses.

Authors and institutions

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA ; Columbia University, 5992 Lerner Hall, 2920 Broadway, New York, NY 10027, USA.

Funding

  • NCI NIH HHS
  • National Institutes of Health
  • American Institute for Cancer Research

Cite

APA

Woode, D. R., Aiyer, H. S., Sie, N., Zwart, A. L., Li, L., Seeram, N. P., & Clarke, R. (2012). Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines. International Journal of Breast Cancer. https://doi.org/10.1155/2012/147828

Vancouver

Woode DR, Aiyer HS, Sie N, Zwart AL, Li L, Seeram NP, et al. Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines. International Journal of Breast Cancer. 2012. doi:10.1155/2012/147828

BibTeX
@article{Woode2012,
  author = {Woode, Denzel R and Aiyer, Harini S and Sie, Nicole and Zwart, Alan L and Li, Liya and Seeram, Navindra P and Clarke, Robert},
  title = {Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines},
  journal = {International Journal of Breast Cancer},
  year = {2012},
  doi = {10.1155/2012/147828}
}
Start for free →